Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity.
We find that prothymosin alpha (PTalpha) selectively enhances transcriptional activation by the estrogen receptor (ER) but not transcriptional activity of other nuclear hormone receptors. This selectivity for ER is explained by PTalpha interaction not with ER, but with a 37-kDa protein denoted REA, for repressor of estrogen receptor activity, a ... protein that we have previously shown binds to ER, blocking coactivator binding to ER. We isolated PTalpha, known to be a chromatin-remodeling protein associated with cell proliferation, using REA as bait in a yeast two-hybrid screen with a cDNA library from MCF-7 human breast cancer cells. PTalpha increases the magnitude of ERalpha transcriptional activity three- to fourfold. It shows lesser enhancement of ERbeta transcriptional activity and has no influence on the transcriptional activity of other nuclear hormone receptors (progesterone receptor, glucocorticoid receptor, thyroid hormone receptor, or retinoic acid receptor) or on the basal activity of ERs. In contrast, the steroid receptor coactivator SRC-1 increases transcriptional activity of all of these receptors. Cotransfection of PTalpha or SRC-1 with increasing amounts of REA, as well as competitive glutathione S-transferase pulldown and mammalian two-hybrid studies, show that REA competes with PTalpha (or SRC-1) for regulation of ER transcriptional activity and suppresses the ER stimulation by PTalpha or SRC-1, indicating that REA can function as an anticoactivator in cells. Our data support a model in which PTalpha, which does not interact with ER, selectively enhances the transcriptional activity of the ER but not that of other nuclear receptors by recruiting the repressive REA protein away from ER, thereby allowing effective coactivation of ER with SRC-1 or other coregulators. The ability of PTalpha to directly interact in vitro and in vivo with REA, a selective coregulator of the ER, thereby enabling the interaction of ER with coactivators, appears to explain its ability to selectively enhance ER transcriptional activity. These findings highlight a new role for PTalpha as a coregulator activity-modulating protein that confers receptor specificity. Proteins such as PTalpha represent an additional regulatory component that defines a novel paradigm enabling receptor-selective enhancement of transcriptional activity by coactivators.
Mesh Terms:
Animals, Blotting, Northern, CHO Cells, Cricetinae, DNA, Complementary, Dose-Response Relationship, Drug, Gene Library, Glutathione Transferase, Histone Acetyltransferases, Humans, Intracellular Signaling Peptides and Proteins, Models, Biological, Nuclear Receptor Coactivator 1, Nuclear Receptor Coactivators, Plasmids, Precipitin Tests, Protein Binding, Protein Biosynthesis, Protein Precursors, Proteins, Receptors, Estrogen, Thymosin, Transcription Factors, Transcription, Genetic, Transcriptional Activation, Transfection, Transforming Growth Factor beta, Tumor Cells, Cultured, Two-Hybrid System Techniques
Animals, Blotting, Northern, CHO Cells, Cricetinae, DNA, Complementary, Dose-Response Relationship, Drug, Gene Library, Glutathione Transferase, Histone Acetyltransferases, Humans, Intracellular Signaling Peptides and Proteins, Models, Biological, Nuclear Receptor Coactivator 1, Nuclear Receptor Coactivators, Plasmids, Precipitin Tests, Protein Binding, Protein Biosynthesis, Protein Precursors, Proteins, Receptors, Estrogen, Thymosin, Transcription Factors, Transcription, Genetic, Transcriptional Activation, Transfection, Transforming Growth Factor beta, Tumor Cells, Cultured, Two-Hybrid System Techniques
Mol. Cell. Biol.
Date: Sep. 01, 2000
PubMed ID: 10938099
View in: Pubmed Google Scholar
Download Curated Data For This Publication
127297
Switch View:
- Interactions 1